Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3422]
News [7838]
Articles [63]
Editorials [9]
Conferences [211]
elearning [49]
Update from KAITLIN for high-risk HER2-positive early breast cancer
Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA
Update from KAITLIN for high-risk HER2-positive early breast cancer ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )
29 May 2020
Cisplatin plus/minus veliparib in metastatic TNBC and/or germline BRCA...
Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA
Cisplatin plus/minus veliparib in metastatic TNBC and/or germline BRCA-associated breast cancer ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )
29 May 2020
Better genetic diagnostics in Ugandan breast cancer patients
Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA
Better genetic diagnostics in Ugandan breast cancer patients ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )
29 May 2020
ADAURA results: Adjuvant osimertinib for EGFRm non-small cell lung cancer
Prof Roy Herbst - Yale Cancer Center, New Haven, USA
ADAURA results: Adjuvant osimertinib for EGFRm non-small cell lung cancer ( Prof Roy Herbst - Yale Cancer Center, New Haven, USA )
29 May 2020
Pembrolizumab plus chemotherapy for patients with metastatic triple-negative...
Dr Javier Cortés - IOB Institute of Oncology, Madrid and Barcelona, Spain
Pembrolizumab plus chemotherapy for patients with metastatic triple-negative breast cancer ( Dr Javier Cortés - IOB Institute of Oncology, Madrid and Barcelona, Spain )
27 May 2020
COM701 as a monotherapy and in combination with nivolumab for various advanced...
Dr. Ecaterina Dumbrava - MD Anderson Cancer Centre, Houston, USA
COM701 as a monotherapy and in combination with nivolumab for various advanced solid tumours ( Dr. Ecaterina Dumbrava - MD Anderson Cancer Centre, Houston, USA )
27 May 2020
Economic and research benefits of the AORTIC meeting
Prof Ahmed Elzawawy - Suez Canal University, Ismailia, Egypt
Economic and research benefits of the AORTIC meeting ( Prof Ahmed Elzawawy - Suez Canal University, Ismailia, Egypt )
6 May 2020
Meet the Expert: Dr Bodour Salhia
Dr Bodour Salhia - University of Southern California, Los Angeles, USA
Meet the Expert: Dr Bodour Salhia ( Dr Bodour Salhia - University of Southern California, Los Angeles, USA )
1 May 2020
IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients...
Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia
IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients with BRAFV600 mutation-positive advanced melanoma ( Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia )
1 May 2020
New oncogenic drivers in NSCLC
Prof Egbert Smit - Netherlands Cancer Institute, Amsterdam, Netherlands
New oncogenic drivers in NSCLC ( Prof Egbert Smit - Netherlands Cancer Institute, Amsterdam, Netherlands )
23 Apr 2020
The potential of KRAS inhibitors for non-small-cell lung cancer
Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany
The potential of KRAS inhibitors for non-small-cell lung cancer ( Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany )
22 Apr 2020
Using cancer research strategies to develop an anti-coronavirus vaccine
Dr Bernard Fox - Providence Cancer Institute, Portland, USA
Using cancer research strategies to develop an anti-coronavirus vaccine ( Dr Bernard Fox - Providence Cancer Institute, Portland, USA )
20 Apr 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation